Advertisement

Progression and Regression of Advanced Atherosclerosis as Studied by Quantitative Methods

  • Robert W. Wissler
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 51)

Abstract

In this presentation, the evidence will be reviewed which indicates that the incidence and severity of atherosclerosis and its clinical effects can be altered significantly by dietary and other factors. The main goals will be to put this evidence in perspective, to call attention to its shortcomings and then to outline the studies that appear to be most urgently needed. Before considering the ways one may measure progression and regression of atherosclerotic plaques, it is important to understand the main features of atherosclerosis in humans.

Keywords

Rhesus Monkey Atherosclerotic Plaque Cholesterol Ester Artery Wall Fatty Streak 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    H.C. McGill, Jr., The lesion, in: “Atherosclerosis III.” G. Schettler and A. Weizel, eds., p. 27, Springer Verlag, Berlin (1974).CrossRefGoogle Scholar
  2. 2.
    R.W. Wissler, Development of the atherosclerotic plaque, in: “The Myocardium. Failure and Infarction,” E. Braunwald, ed. p. 155, H.P. Publishing Co. Inc., New York (1974).Google Scholar
  3. 3.
    R.W. Wissler, Principles of the pathogenesis of athero sclerosis, in: “Heart Disease. A Textbook of Cardio-vascular Medicine,” E. Braunwald, ed., Vol. 2, p. 1221, W.B. Saunders Co., Philadelphia (1980).Google Scholar
  4. 4.
    G.S. Berenson, S.R. Srinivasan, B. Radhakrishnamurthy, and E.R. Dalferes, Mucopholysaccharide-lipoprotein complexes in atherosclerotic aorta, in: “Arterial Mesenchyme and Arteriosclerosis,” W.D. Wagner and T.B. Clarkson, eds., p. 141, Plenum Press, New York (1974).Google Scholar
  5. 5.
    T. Schaffner, K. Taylor, E.J. Bartucci, K. Fischer-Dzoga, J.H. Beeson, S. Glagov and R.W. Wissler, Arterial foam cells exhibit distinctive immunomorphologic and histo-chemical features of macrophages, Am. J. Path. 100: 57 (1980).PubMedGoogle Scholar
  6. 6.
    M.D. Haust, R.H. More, and H.Z. Movat, The role of smooth muscle cells in the fibrogenesis of arteriosclerosis, Am. J. Path. 37: 377 (1960).PubMedGoogle Scholar
  7. 7.
    J.C. Geer, H.C. McGill, Jr., J.P. Strong, and R.L. Holman, Electron microscopy of human atherosclerotic lesions, Fed. Proc. 19: 15 (1960).Google Scholar
  8. 8.
    R.W. Wissler, The arterial medial cell, smooth muscle or multifunctional mesenchyme? J. Atheros. Res. 8: 201 (1968).CrossRefGoogle Scholar
  9. 9.
    R. Ross, The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers, J. Cell Biol. 50: 172 (1971).PubMedCrossRefGoogle Scholar
  10. 10.
    R.W. Wissler, D. Vesselinovitch, and G.S. Getz, Abnor malities of the arterial wall and its metabolism in atherogenesis, Progr. Cardiovasc. Pis. 18: 341 (1976).CrossRefGoogle Scholar
  11. 11.
    R. Ross and J. Glomset, The pathogenesis of atherosclerosis (Part 1), New Eng. J. Med. 295: 369 (1976).CrossRefGoogle Scholar
  12. 12.
    R. Ross and J. Glomset, The pathogenesis of atherosclerosis (Part 2), New Eng. J. Med. 295: 420 (1976).CrossRefGoogle Scholar
  13. 13.
    R.W. Wissler, Overview of problems of atherosclerosis, in: “Cerebrovascular Disease,” P. Scheinberg, ed., p. 59, Raven Press, New York (1976)Google Scholar
  14. 14.
    M.L. Tiell and M.B. Stemerman, Suppression of myointimal hyperplasia in hypophysectomized rats, Circulation 54 (Suppl. II): 138 (1976).Google Scholar
  15. 15.
    R.W. Wissler, H.A. McAllister, and D. Vesselinovitch, A histopathological study of the fatty streak in aortas and coronary arteries of young American military personnel, Am J. Path. 78: 64a (1975).Google Scholar
  16. 16.
    E.B. Smith and R.S. Slater, Lipids and low-density lipoproteins in intima in relation to its morphological characteristics, in: “Atherogenesis: Initiating Factors” (Ciba Symposium), p. 39, Excerpta Medica, Amsterdam (1974).Google Scholar
  17. 17.
    R.V. Panganamala, J.C. Geer, H.M. Sharma, and D.G. Cornwell, The gross and histologic appearance and the lipid com-position of normal intima and lesions from human coronary arteries and aorta, Atherosclerosis 20: 93 (1974).PubMedCrossRefGoogle Scholar
  18. 18.
    J.R.A. Mitchell and C.J. Schwartz, “Arterial Disease” Blackwell, Oxford (1965).Google Scholar
  19. 19.
    R.W. Wissler, Atherosclerosis — Its pathogenesis in prespective, in: “Comparative Pathology of the Heart.” (Adv. Cardiol. Vol 13) F. Homberger, ed., p. 10, S. Karger, Basel (1974).Google Scholar
  20. 20.
    D. Vesselinovitch, G.S. Getz, R.H. Hughes, and R.W. Wissler, Atherosclerosis in the rhesus monkey fed three food fats, Atherosclerosis 20: 303 (1974).PubMedCrossRefGoogle Scholar
  21. 21.
    R.W. Wissler, D. Vesselinovitch, J. Borensztajn, T.Schaffner, and R. Hughes, Effect of various dietary responses on progression of atherosclerosis in rhesus monkeys, Fed. Proc. 35: 294 (1976).Google Scholar
  22. 22.
    D. Vesselinovitch, R.W. Wissler, T.J. Schaffner, and J. Borensztajn, The effects of various diets on atherogenesis in rhesus monkeys, Atherosclerosis 35: 189 (1980).PubMedCrossRefGoogle Scholar
  23. 23.
    L.N. Katz and J. Stamler, “Experimental Atherosclerosis,” Thomas, Springfield, 111. (1953).Google Scholar
  24. 24.
    P. Constantinides, “Experimental Atherosclerosis,” Elsevier, Amsterdam (1965).Google Scholar
  25. 25.
    J.C. Roberts and R. Straus, “Comparative Atherosclerosis,” Hoeber, New York (1965).Google Scholar
  26. 26.
    R.W. Wissler and D. Vesselinovitch, Evaluation of animal models for the study of the pathogenesis of atherosclerosis, ins: “International Symposium: State of Prevention and Therapy in Human Atherosclerosis and in Animal Models,” W.H. Hauss, R.W. Wissler and R. Lehmann, eds., p. 13, Westdeutscher Verlag, Opladen, W. Germany (1978).Google Scholar
  27. 27.
    D. Vesselinovitch, Animal models of atherosclerosis, their contributions and pitfalls, Artery 5: 193 (1979).PubMedGoogle Scholar
  28. 28.
    G. Schettler, Cardiovascular diseases during and after World War II: A comparison of the Federal Republic of Germany with other European countries, Prev. Med. 8: 581 (1979).PubMedCrossRefGoogle Scholar
  29. 29.
    M.R. Malinow, Regression of atherosclerosis in non-human primates. An overview, in: “The Use of Non-human Primates Cardiovascular Diseases,” S.S. Kalter, ed., p. 181, Univ. Texas Press, Austin, (1980).Google Scholar
  30. 30.
    A.E. Dorr, K. Gundersen, J.C. Schneider, Jr., T.W. Spencer, and W.B. Martin, Colestipol hydrochloride in hyper-cholesterolemic patients — effect on serum cholesterol and mortality, J. Chron. Pis. 31: 5 (1978).CrossRefGoogle Scholar
  31. 31.
    N.J. Stone, Cholesterol, colestipol and coronary heart disease, J. Chron. Pis. 31: 1 (1978).CrossRefGoogle Scholar
  32. 32.
    O. Turpeinen, Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes, Circulation 59: 1 (1979).PubMedGoogle Scholar
  33. 33.
    P. Leren, The Oslo diet — heart study: Eleven-year report. Circulation 42: 935 (1970).PubMedGoogle Scholar
  34. 34.
    S.L. Wilens, The resorption of arterial atheromatous de posits in wasting disease, Am. J.Path. 23: 793 (1947).PubMedGoogle Scholar
  35. 35.
    H. Buchwald, K. Amplatz, L. Knight, I. Guzman, and R.L. Varco, Arteriography changes after partial ileal bypass, in: “International Symposium: State of Prevention and Therapy in Human Arteriosclerosis and in Animal Models,” W.H. Hauss, R.W. Wissler and R. Lehmann, eds., p. 469, Westdeutscher Verlag, Opladen, West Germany (1978).Google Scholar
  36. 36.
    R. Barndt, Jr., P.H. Blankenhorn, P.W. Crawford, and S.H. Brooks, Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients, Ann. Int. Med. 86: 139 (1977).PubMedGoogle Scholar
  37. 37.
    I. Vartiainen and K. Kanerva, Artherosclerosis in wartime, Ann med, int. Fenniae 36: 748 (1947).Google Scholar
  38. 38.
    K. Solth, R. Kohl, G. Schettler, and A. Werthemann, Zur Statistik der Arteriosklerose, Verh. Peut. Ges. Pathol. 41: 64: (1957).Google Scholar
  39. 39.
    U.A. Rivin and S.P. Pimitroff, The incidence and severity of atherosclerosis in estrogen-treated males, and in females with a hypoestrogenic or a hyperestrogenic state, Circulation 9: 533 (1954).Google Scholar
  40. 40.
    M.S. Moskowitz, A.A. Moskowitz, W.L. Bradford, and R.W. Wissler, Changes in serum lipids and coronary arteries of the rat in response to estrogens, Arch. Path. 61: 245 (1956).Google Scholar
  41. 41.
    J. Stamler, R. Pick, and L.N. Katz, Experiences in assessing estrogen antiatherogenesis in the chick, the rabbit and man, Ann. N.Y. Acad. Sci. 64: 596 (1956).PubMedCrossRefGoogle Scholar
  42. 42.
    W.T. London, S.E. Rosenberg, J.W. Praper, and T.P. Almy, The effect of estrogen on atherosclerosis, Ann. Int. Med. 55: 63 (1961).Google Scholar
  43. 43.
    H. Buchwald, R. B. Moore and R.L. Varco, Surgical treatment of hyperlipidemia, Circulation 49 (suppl. I.):l (1974).Google Scholar
  44. 44.
    P. Constantinides, J. Booth, and G. Carlson, Production of advanced cholesterol atherosclerosis in the rabbit, Arch. Path. 70: 712 (1960).PubMedGoogle Scholar
  45. 45.
    R.W. Wissler, and D. Vesselinovitch, Experimental models of human atherosclerosis, Ann. N.Y. Acad. Sci. 149: 907 (1968).PubMedGoogle Scholar
  46. 46.
    R.W. Wissler, and D. Vesselinovitch, Difference between human and animal atherosclerosis, in: “Atherosclerosis III,” G. Schettler and A. Weizel, eds., p. 319, Springer- Verlag, Berlin (1974).CrossRefGoogle Scholar
  47. 47.
    R. Wissler and D. Vesselinovitch, Studies of regression of advanced atherosclerosis in experimental animals and man, in: “Atherogenesis,” Ann. N.Y. Acad. Sci. 275: 363 (1976).Google Scholar
  48. 48.
    D. Vesselinovitch and R.W. Wissler, Comparison of primates and rabbits as animal models in experimental athero-sclerosis, in: “Atherosclerosis: Metabolic, Morphologic and Clinical Aspects,” G.W. Manning and M.D. Haust; eds., p. 614, Plenum Press, New York (1977).Google Scholar
  49. 49.
    R.W. Wissler, and D. Vesselinovitch, Animal models of regression, in: “Atherosclerosis IV,” G. Schettler, Y. Goto, Y. Hata and G. Klose, eds., p. 377, Springer- Verlag, Berlin (1977).Google Scholar
  50. 50.
    R.W. Wissler and D. Vesselinovitch, Evaluation of animal models for the study of the pathogenesis of athero-sclerosis, in: “International Symposium. State of Prevention and Therapy in Human Arteriosclerosis and in Animal Models,” W.H. Hauss, R.W. Wissler and R. Lehmann, eds., p. 13, Westdeutscher Verlag, Opladen, West Germany (1978).Google Scholar
  51. 51.
    D. Vesselinovitch and R.W. Wissler, Prevention and regression in animal models by diet and cholestyramine, in: “International Symposium. State of Prevention and Therapy in Human Arteriosclerosis and in Animal Models,” W.H. Hauss, R.W. Wissler, and R. Lehmann, eds., p. 127, Westdeutscher Verlag, Opladen, West Germany (1978).Google Scholar
  52. 52.
    A. Wartman, T.L. Lampe, P.S. McCann, and A.J. Boyle, Plaque reversal with Mg EDTA in experimental athero-sclerosis: elastin and collagen metabolism, J, Atheroscler. Res. 7: 331 (1967).CrossRefGoogle Scholar
  53. 53.
    K. Kjeldsen, P. Astrup, and J. Wanstrup, Reversal of rabbit atheromatosis by hyperoxia, J. Atheroscler. Res. 10: 173 (1969).PubMedCrossRefGoogle Scholar
  54. 54.
    D. Vesselinovitch, R.W. Wissler, K. Fischer-Dzoga, R. Hughes, and L. DuBien, Regression of atherosclerosis in rabbits. I. Treatment with low fat diet, hyperoxia and hypolipi-demic agents,Atherosclerosis 19: 259 (1974).PubMedCrossRefGoogle Scholar
  55. 55.
    C.B. Taylor, G.E. Cox, P. Manalo-Estrella, and J. South-worth, Atherosclerosis in rhesus monkeys. II. Arterial lesions associated with hypercholesterolemia induced by dietary fat and cholesterol, Arch. Pathol. 74: 16 (1962).PubMedGoogle Scholar
  56. 56.
    C.B. Taylor, D.E. Patton, and G.E. Cox, Atherosclerosis in rhesus monkeys.VI.Fatal myocardial infarction in a monkey fed fat and cholesterol. Arch. Pathol. 76: 404 (1963).PubMedGoogle Scholar
  57. 57.
    C.B. Taylor, Experimentally induced atherosclerosis in non-human primates, in: “Comparative Atherosclerosis,” J.C. Roberts and R. Strauss, eds., p. 215, Hoeber, New York (1965).Google Scholar
  58. 58.
    M.L. Armstrong, E.D. Warner, and W.E. Connor, Regression of coronary atheromatosis in rhesus monkeys, Circul. Res. 27: 59 (1970).Google Scholar
  59. 59.
    R.W. Wissler, Current status of regression studies, in: “Atherosclerosis Reviews,” Vol. 3, R. Paoletti and A.M. Gotto, eds., p. 213, Raven Press, New York (1978).Google Scholar
  60. 60.
    M.L. Armstrong and M.B. Megan, Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets, Circul. Res. 30: 675 (1972).Google Scholar
  61. 61.
    M.L. Armstrong, Connective tissue changes in regression, in: “Atherosclerosis IV,” G. Schettler, Y. Goto, Y. Hata, G. Klose, eds., p. 405, Springer-Verlag, Berlin (1977).Google Scholar
  62. 62.
    D. Vesselinovitch, R.W. Wissler, R. Hughes, and J. Borensztajn, Reversal of advanced atherosclerosis in rhesus monkeys. I. Gross and light microscopic studies, Atherosclerosis 23: 155 (1976).CrossRefGoogle Scholar
  63. 63.
    R.W. Wissler, unpublished observation.Google Scholar
  64. 64.
    R.M. Jones, and R.W. Wissler, Surface features of experimental atherosclerotic plaques in rhesus monkeys with and without treatment, in: Scanning Electron Microscopy, Part II., O. Johari, ed., p. 975, SEM, Inc., Chicago (1978).Google Scholar
  65. 65.
    G. Weber, P. Fabbrini, L. Resi, R. Jones, D. Vesselinovitch, and R.W. Wissler, Regression of arteriosclerotic lesions in rhesus monkey aortas after regression diet: scanning and transmission electron microscope observations of the endothelium, Atherosclerosis 26: 535 (1977).PubMedCrossRefGoogle Scholar
  66. 66.
    J. Borensztajn, K. Foreman, R.W. Wissler, H. VanZutphen, D. Vesselinovitch, and R. Hughes, Egress of aortic cholesterol and cholesterol ester during regression of atherosclerosis in rhesus monkeys, Circulation 52 (Suppl. II): 269 (1975).Google Scholar
  67. 67.
    D. Vesselinovitch, R.W. Wissler, J. Borensztajn, and T.J. Schaffner, The effects of diets with and without cholestyramine on the lesion compoments of atherosclerotic plaques, Fed. Proc. 37: 835 (1978).Google Scholar
  68. 68.
    D. Vesselinovitch, R.W. Wissler, and T.J. Schaffner, Quantitation of lesions during progression and regression of atherosclerosis in rhesus monkeys. Symposium on Cardiovascular Disease in Nutrition (19th Annual Meeting, Am. Assn. Nutrition, U. Minn.), Spectrum Publications, New York, in press (1979).Google Scholar
  69. 69.
    R.W. Wissler, D. Vesselinovitch, T.J. Schaffner, and S. Glagovy Quantitating rhesus monkey atherosclerosis progression and regression with time, in: “Atherosclerosis V,” A.M. Gotto, Jr., L.C. Smith and B. Allen, eds., p. 757, Springer-Verlag New York (1980).Google Scholar
  70. 70.
    D.A. Eggen, J.P. Strong, and H.C. McGill, Jr., An objective method for grading atherosclerotic lesions, Lab. Invest. 11: 732 (1962).PubMedGoogle Scholar
  71. 71.
    C.F. Howard, Jr., Aortic atherosclerosis in normal and spontaneously diabetic Macaca nigra, Atherosclerosis 33: 479 (1979).PubMedCrossRefGoogle Scholar
  72. 72.
    B. Radhakrishnamurthy, H.A. Ruiz, E.R. Dalferes, Jr., D. Vesselinovitch, R.W. Wissler and G.S. Berenson, The effect of various dietary regimens and cholestyramine on aortic glycosaminoglycans during regression of atherosclerotic lesions in rhesus monkeys, Atherosclerosis 33: 17 (1979).PubMedCrossRefGoogle Scholar
  73. 73.
    A.J. Daoud, J. Jarmolych, J. Augustyn, K.E. Fritz, J.K. Singh, and K.T. Lee, Regression of advanced swine athero-sclerosis, Arch. Pathol. Lab. Hed. 100: 372 (1976).Google Scholar
  74. 74.
    K.E. Fritz, J. Augustyn, J. Jarmolych, A.S. Daoud and K.T. Lee, Regression of advanced atherosclerosis in swine (chemical studies), Arch. Pathol. Lab. Med. 100: 380 (1976).PubMedGoogle Scholar
  75. 75.
    R.H. Knopp, Test of the lipid hypothesis: The coronary primary prevention trial (COPT) of the lipid research clinics program, in: “Atherosclerosis V” A.M. Gotto, Jr., L.C. Smith, B. Allen, p. 509, Springer-Verlag, New York (1980).Google Scholar
  76. 76.
    D.W. Crawford, E.S. Beckenbach, D.H. Blankenhorn, R.H. Selzer, and S.H. Brooks, Grading of coronary atherosclerosis. Comparison of a modified IAP visual grading method and a new quantitative angiographic technique, Atherosclerosis, 19: 231 (1974).PubMedCrossRefGoogle Scholar
  77. 77.
    D.W. Crawford and D.H. Blankenhorn, Quantitative studies of atherosclerotic plaque size in human subjects, in: “International Symposium: State of Prevention and Therapy in Human Arteriosclerosis and in Animal Models,” W.H. Hauss, R.W. Wissler, and R. Lehmann, eds., p. 55, Westdeutscher Verlag, Opladen, West Germany (1978).Google Scholar
  78. 78.
    R.W. Barnes, Doppler ultrasonic arteriography and flow velocity analysis in carotid artery disease, in: “Non-invasive Diagnostic Techniques in Vascular Disease,” E.F. Borenstein, ed., p. 221, C.V. Mosby Company, St. Louis (1978).Google Scholar
  79. 79.
    D. Nash, Personal communication.Google Scholar
  80. 80.
    D.H. Blankenhorn, Personal communication.Google Scholar
  81. 81.
    R. Ross and J.A. Glomset, The pathogenesis of atherosclerosis, New Eng. J. Med. 295: 369 (1976).PubMedCrossRefGoogle Scholar
  82. 82.
    C.M. Gajdusek, P. DiCorleto, R. Ross, and S.M. Schwartz, An endothelial cell derived growth factor, J. Cell Biology 85: 467 (1980).CrossRefGoogle Scholar
  83. 83.
    K. Fischep-Dzoga, R. Fraser, and R.W. Wissler, Stimulation of proliferation in stationary primary cultures of monkey and rabbit aortic smooth muscle cells. I. Effects of lipoprotein fractions of hyperlipemic serum and lymph, Exp. Mol. Pathol. 24: 346 (1976).CrossRefGoogle Scholar
  84. 84.
    H.G. Stary, Ultrastructural changes in the lipid inclusions of a arterial smooth muscle cells after reduction of high serum cholesterol levels, Progress in Biochem. Pharmacol 14: 46 (1977).Google Scholar
  85. 85.
    A.S. Daoud, J. Jarmolych, J.M. Augustyn, and K.E. Fritz, Sequential morphologic studies of regression of advanced atherosclerosis, Arch. Path. 105: 233 (1981).Google Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Robert W. Wissler
    • 1
    • 2
  1. 1.The Department of PathologyThe University of ChicagoChicagoUSA
  2. 2.The Specialized Center of Research in AtherosclerosisThe University of ChicagoChicagoUSA

Personalised recommendations